Digital Therapeutics to ensure
continuity of Diabetes Care
in Times of COVID 19
R. Adhikary , S. Joshi,
R.K. Sahay, Dr. B. Saboo
Digital Therapeutics to ensure continuity of diabetes care in times of COVID 19
R. Adhikary , S. Joshi, R.K. Sahay, Dr. B. Saboo
Objective
Wellthy CARE™ Digital Therapeutic platform (WDTx), is based on the AADE7 self care behaviors.
Diabetes self-care and management challenged during the 68-day nationwide lockdown
in India due to the Coronavirus disease (COVID-19) pandemic.
This study evaluates the impact of early app interactions on a DTx platform as a predictive
digital biomarker to determine app engagement and clinical outcomes.
Indication
Method
WDTx comprises a patient facing mobile application enabling patient logs with AI-augmented real-time feedback, evidence-based guidelines and remote health coaching.
